Movement Alert｜Oscar Health, Inc. Intraday Rise 5.19%, UBS Says Q3 Upside May Be More Limited After Guidance Update

Market Focus10-19

On October 19, Oscar Health, Inc. rose 5.19% in Regular Trading, trading at $33.51, with turnover of $10.2547 million.

The key catalyst in recent coverage was a research note indicating that the company’s updated outlook already reflects favorable medical utilization trends, which could limit the scope for a major upside surprise when third-quarter results are released on November 5.

In that update, earnings-per-share estimates for 2026 through 2028 were raised to $2.00, $2.30 and $2.80, and the price target was lifted to $36 from $26, while the rating was kept at Neutral. The same note also flagged that eligibility checks on a large member cohort could pressure revenue if disenrollment is elevated, although management indicated the effect could be absorbed within current guidance. Oscar Health, Inc. last reported quarterly EPS of $1.10 on revenue of $4.88 billion, both above expectations.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment